Our Blog Melanoma360

Blog - Melanoma360

Featured image for “In Plain English: Tumor-Infiltrating Lymphocyte (“TIL”) Therapy for Advanced Melanoma”
11/16/2022

In Plain English: Tumor-Infiltrating Lymphocyte (“TIL”) Therapy for Advanced Melanoma

By Kim Margolin, M.D., FACP, FASCO Background—Immunotherapy of melanoma The explosion of immunotherapy over the past decade has revolutionized the…
Blog - Melanoma360
In Plain English
Featured image for “Iovance Biotherapeutics Announces Updated Clinical Data for Lifileucel in Advanced Melanoma at Society for Immunotherapy of Cancer (SITC) Annual Meeting”
11/11/2022

Iovance Biotherapeutics Announces Updated Clinical Data for Lifileucel in Advanced Melanoma at Society for Immunotherapy of Cancer (SITC) Annual Meeting

(November 07, 2022 08:01 ET | Source: Iovance Biotherapeutics, Inc. ) Clinically Meaningful and Durable Activity in Largest Cell Therapy…
Blog - Melanoma360
Breaking News
Melanoma Research
Featured image for “Living Beyond Melanoma: A Conversation with Stage IV Melanoma Survivor, Stephanie Bowen”
11/08/2022

Living Beyond Melanoma: A Conversation with Stage IV Melanoma Survivor, Stephanie Bowen

In this episode, Melissa Wilson, PA-C, MPAS, AIM’s “Ask a Medical Expert” and host of the webinar series, “From the…
Blog - Melanoma360
Podcast
Featured image for “Diagnosed with Melanoma as a Teenager Changed My Life’s Course”
11/07/2022

Diagnosed with Melanoma as a Teenager Changed My Life’s Course

By Mara Klecker Madison Goff spent her early teenage years tanning in her family’s tanning bed or laying by the…
Blog - Melanoma360
Survivor Stories
Featured image for “Create a Legacy with AIM”
10/12/2022

Create a Legacy with AIM

October 17th – 23rd, 2022 is National Estate Planning Awareness Week Creating a legacy gift that supports melanoma research in…
Blog - Melanoma360
Philanthropy
Featured image for “Talking to Your Care Team about Your Sexual Orientation and Gender Identity”
10/11/2022

Talking to Your Care Team about Your Sexual Orientation and Gender Identity

While it may be an uncomfortable topic to bring up, sharing your sexual orientation and gender identity with your cancer…
Blog - Melanoma360
Podcast
Featured image for “Giving immunotherapy before targeted therapy improves survival in patients with advanced melanoma”
09/30/2022

Giving immunotherapy before targeted therapy improves survival in patients with advanced melanoma

(Source:Georgetown University Medical Center) Originally published Sep 27, 2022, Medical Life Sciences Giving immunotherapy before targeted therapy improves survival in…
Blog - Melanoma360
Breaking News
Featured image for “Val Guild Honored at 2022 ASCO Annual Conference”
09/29/2022

Val Guild Honored at 2022 ASCO Annual Conference

by Alicia Rowell, Vice President Saturday, June 4 was a special evening. In Chicago that week many of the nation’s…
Blog - Melanoma360
Uncategorized
Featured image for “President’s Letter | September 2022”
09/27/2022

President’s Letter | September 2022

From the Desk of Samantha Guild Leaves are falling, pumpkins are out, football is on TV, and the kids are…
Blog - Melanoma360
President's Letter
Featured image for “AIM Welcomes Ann Garst Taylor as New Director of Community Engagement”
09/27/2022

AIM Welcomes Ann Garst Taylor as New Director of Community Engagement

By Mara Klecker Ann Garst Taylor, AIM at Melanoma’s new Director of Community Engagement, has nearly 30 years of volunteer…
Blog - Melanoma360
Uncategorized
11/16/2022

In Plain English: Tumor-Infiltrating Lymphocyte (“TIL”) Therapy for Advanced Melanoma

By Kim Margolin, M.D., FACP, FASCO Background—Immunotherapy of melanoma The explosion of immunotherapy over the past decade has revolutionized the…
Featured image for “In Plain English: Tumor-Infiltrating Lymphocyte (“TIL”) Therapy for Advanced Melanoma”
Blog - Melanoma360
 | 
In Plain English
11/11/2022

Iovance Biotherapeutics Announces Updated Clinical Data for Lifileucel in Advanced Melanoma at Society for Immunotherapy of Cancer (SITC) Annual Meeting

(November 07, 2022 08:01 ET | Source: Iovance Biotherapeutics, Inc. ) Clinically Meaningful and Durable Activity in Largest Cell Therapy…
Featured image for “Iovance Biotherapeutics Announces Updated Clinical Data for Lifileucel in Advanced Melanoma at Society for Immunotherapy of Cancer (SITC) Annual Meeting”
Blog - Melanoma360
 | 
Breaking News
 | 
Melanoma Research
11/08/2022

Living Beyond Melanoma: A Conversation with Stage IV Melanoma Survivor, Stephanie Bowen

In this episode, Melissa Wilson, PA-C, MPAS, AIM’s “Ask a Medical Expert” and host of the webinar series, “From the…
Featured image for “Living Beyond Melanoma: A Conversation with Stage IV Melanoma Survivor, Stephanie Bowen”
Blog - Melanoma360
 | 
Podcast
11/07/2022

Diagnosed with Melanoma as a Teenager Changed My Life’s Course

By Mara Klecker Madison Goff spent her early teenage years tanning in her family’s tanning bed or laying by the…
Featured image for “Diagnosed with Melanoma as a Teenager Changed My Life’s Course”
Blog - Melanoma360
 | 
Survivor Stories
10/12/2022

Create a Legacy with AIM

October 17th – 23rd, 2022 is National Estate Planning Awareness Week Creating a legacy gift that supports melanoma research in…
Featured image for “Create a Legacy with AIM”
Blog - Melanoma360
 | 
Philanthropy
10/11/2022

Talking to Your Care Team about Your Sexual Orientation and Gender Identity

While it may be an uncomfortable topic to bring up, sharing your sexual orientation and gender identity with your cancer…
Featured image for “Talking to Your Care Team about Your Sexual Orientation and Gender Identity”
Blog - Melanoma360
 | 
Podcast
09/30/2022

Giving immunotherapy before targeted therapy improves survival in patients with advanced melanoma

(Source:Georgetown University Medical Center) Originally published Sep 27, 2022, Medical Life Sciences Giving immunotherapy before targeted therapy improves survival in…
Featured image for “Giving immunotherapy before targeted therapy improves survival in patients with advanced melanoma”
Blog - Melanoma360
 | 
Breaking News
09/29/2022

Val Guild Honored at 2022 ASCO Annual Conference

by Alicia Rowell, Vice President Saturday, June 4 was a special evening. In Chicago that week many of the nation’s…
Featured image for “Val Guild Honored at 2022 ASCO Annual Conference”
Blog - Melanoma360
 | 
Uncategorized
09/27/2022

President’s Letter | September 2022

From the Desk of Samantha Guild Leaves are falling, pumpkins are out, football is on TV, and the kids are…
Featured image for “President’s Letter | September 2022”
Blog - Melanoma360
 | 
President's Letter
09/27/2022

AIM Welcomes Ann Garst Taylor as New Director of Community Engagement

By Mara Klecker Ann Garst Taylor, AIM at Melanoma’s new Director of Community Engagement, has nearly 30 years of volunteer…
Featured image for “AIM Welcomes Ann Garst Taylor as New Director of Community Engagement”
Blog - Melanoma360
 | 
Uncategorized